Yifan Pharmaceutical financials at a glance

+ Portfolio

The revenue of Yifan Pharmaceutical is reported as 4.06811 billion Yuan Renminbi in the fiscal year 2023. The earnings were 0 Yuan Renminbi per share in 2023, which was 155.56 higher than 2012. And about -0.15551 billion Yuan Renminbi are reported as free cash flow in the financials of Yifan Pharmaceutical 2023. No dividends were paid to the shareholders of the Yifan Pharmaceutical stock SZSE:002019 in the financial year 2023.

Forecast

Financials

Year	Year	TTM	2013	2012	2011	2010	2009	2006
Rev.	Revenue	N/A	¥0.00M	¥0.00M	¥491.65M	¥379.88M	¥0.00M	¥0.00M
GM %	Gross Margin %	48.00%	31.23%	22.79%	-10.97%	26.14%	33.40%	35.29%
OM	Operating Margin	2.51%	13.34%	3.22%	-39.04%	-6.04%	9.90%	7.54%
EPS	Earnings Per Share	¥0.11	¥0.05	¥-0.09	¥-0.41	¥-0.34	¥0.05	¥0.00
Div.	Dividends	N/A	¥0.00	¥0.00	¥0.00	¥0.00	¥0.00	¥0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0
Sha.	Shares	N/AM	551.05M	551.05M	551.05M	551.05M	551.05M	477.75M
OCF	Operating Cash Flow	N/A	¥0.00M	¥0.00M	¥0.00M	¥0.00M	¥0.00M	¥0.00M
FCF	Free Cash Flow	N/A	¥0.00M	¥0.00M	¥0.00M	¥0.00M	¥0.00M	¥0.00M
FCFS	Free Cash Flow Per Share	¥-0.11	¥0.02	¥-0.07	¥-0.28	¥-0.42	¥-0.18	¥-0.06

Yifan Pharmaceutical financials at a glance

Financials

Discover